ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RDT Rosslyn Data Technologies Plc

10.25
-0.25 (-2.38%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Rosslyn Data Technologies Plc LSE:RDT London Ordinary Share GB00BMV2DB09 ORD GBP0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.25 -2.38% 10.25 10.00 10.50 10.50 10.25 10.50 32,808 15:01:12
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Computer Programming Service 4.52M 372k 0.0211 4.86 1.81M
Rosslyn Data Technologies Plc is listed in the Computer Programming Service sector of the London Stock Exchange with ticker RDT. The last closing price for Rosslyn Data Technologies was 10.50p. Over the last year, Rosslyn Data Technologies shares have traded in a share price range of 10.25p to 41.25p.

Rosslyn Data Technologies currently has 17,659,275 shares in issue. The market capitalisation of Rosslyn Data Technologies is £1.81 million. Rosslyn Data Technologies has a price to earnings ratio (PE ratio) of 4.86.

Rosslyn Data Technologies Share Discussion Threads

Showing 1426 to 1450 of 2025 messages
Chat Pages: Latest  69  68  67  66  65  64  63  62  61  60  59  58  Older
DateSubjectAuthorDiscuss
06/4/2022
06:31
Well, should be news very soon as I've heard that the new product and brand launch are very close! Additionally, RDT now has a PR company on board which is a first, perhaps suggesting the tide is turning at last and news ahead likely.Sounding like a broken record, but trading on less than 2xARR and then there is the cash.
hastings
30/3/2022
08:34
It's a bit painful isn't it!There should be something imminent re-the new product launch, but hey ho.
hastings
30/3/2022
07:32
No, I have been watching and at the moment I see nothing to encourage me into reinvesting I’m afraid.

DC

daicaprice
30/3/2022
07:28
The new broom has not swept well at all.
kemche
30/3/2022
07:19
Just keep telling myself to be patient...........!
chrisdgb
01/3/2022
16:45
Still sellers around but they don’t seem to want to mark it down any further to create a market, @3p or just over I’d be very tempted for a long term hold.

DC

daicaprice
09/2/2022
15:46
It’s a tricky one Chris, well undervalued and going to be a profitable long term hold but ………;…

DC

daicaprice
09/2/2022
15:30
This screams buy but do I want to tie up more funds...??
chrisdgb
04/2/2022
16:19
Justin & I talk about Rosslyn (starts 34:40) here in today's Stock Picking video.

www.youtube.com/watch?v=pT7NlRWpmC0&t=2s

brummy_git
31/1/2022
09:06
We’d had the warning but it does look positive from here with new contracts, possible disposal, cash in hand and a new hand on the tiller.

DC

daicaprice
31/1/2022
08:52
Albeit there's still plenty to do, I believe the tools are now in place to drive a material improvement in Rosslyn's performance over the next few years.

Find out why here.

www.linkedin.com/posts/paul-hill-a5994116_rdt-rdt-rdt-activity-6893837081123381248-eucV

brummy_git
31/1/2022
08:10
Well that was a short sharp kick in the danglies. The kindest description would be "work in progress". The unkindest would be unprintable.
kemche
20/1/2022
11:32
The Langdon disposal is a curve ball for me but at the right price............
chrisdgb
14/1/2022
12:49
A couple of large and interesting trades over the last 24 hours!
hastings
13/1/2022
10:21
That's a very good summary Paul, thanks.
hastings
13/1/2022
09:59
My latest thoughts here wrt Rosslyn's trading update today

www.linkedin.com/posts/paul-hill-a5994116_rdt-rdt-rdt-activity-6887316689482989568-PdjA

brummy_git
13/1/2022
09:56
I spoke with the CEO a couple of months back but didn't add a write up at the time.However he did say then that Langdon could be sold, adding it was already run as a separate business that could be worth a decent sum to RDT. He also talked of the US as more recently providing decent contract wins such as the Pharma customer as previously mentioned and he saw plenty to go for over there and potential for decent upside.No surprise either that they are exiting low value business which perhaps in part accounts for reduced revenue.All in all he sees the product as very good, but one that was in need of revamping etc.A name change was also mentioned to better reflect what the business is and where he wants to take it.P
hastings
13/1/2022
09:24
The effect on the share price of the poor trading is mitigated by, with the m/cap at low levels anyway, (a) the significant cash pile which per today's new Cenkos forecast is estimated to be £3.4m at the year end, and (b) the relatively high recurring income. Plus potentially (c) the sale proceeds from Langdon and/or Integritie.

Langdon was only acquired just over two years ago, and should do well in the coming years due to Brexit, so this seems a strange time to divest. Or perhaps RDT want to take advantage of its prospects to maximise the sale proceeds given its apparent lack of synergy with the rest of the Group .

rivaldo
13/1/2022
08:43
Bouncing back nicely after the early sell off.

DC

daicaprice
13/1/2022
07:57
The Group has made good progress so far this financial year, including winning deals for a top 10 global pharmaceutical business, a top 3 global beverage company, and a top 5 UK Law firm.
The best bit, should get a mention.

DC

daicaprice
13/1/2022
07:56
Just looking at the significant shareholders I note Canaccord with 10.3%. Can't say I saw that one before, or perhaps I missed it!
hastings
13/1/2022
07:48
Yes, work in progress still.

DC

daicaprice
13/1/2022
07:17
Also looks as though they plan to sell on the Langdon business reading through the blurb.
hastings
13/1/2022
07:12
Unfortunately the TU contains a profit warning.

RDT provides the following trading update.

During the year, the Group has invested in its growth, with a number of key hires being made, whilst also remaining disciplined on costs and the Board will continue to explore ways to minimise costs. The Group has made good progress so far this financial year, including winning deals for a top 10 global pharmaceutical business, a top 3 global beverage company, and a top 5 UK Law firm. At the same time, there has been a focus on exiting non-profitable business lines, to enable the Company to focus on larger, more profitable contracts. However, and as has been reported previously, larger contracts have lengthy lead times and Covid restrictions that have been experienced across the economy have lengthened these further. Whilst the Company will continue to work hard to secure further contracts before the end of the financial year, the challenges being faced, mean that the Board is taking a more conservative view on the outcome for the year ending 30 April 2022 and now expects revenue to be no less than GBP6.0m, with ARR to be at least GBP5.1m and a corresponding impact on EBITDA.

Paul Watt, CEO, commenting, "Like many businesses we have not been immune to the effects of the pandemic and this is reflected in our anticipated financial performance for the current calendar year. However, with a refreshed leadership team, a great core product and a clear strategy now in place I believe that there are significant opportunities available to the Group to drive growth and deliver shareholder value and am excited to look to the future."

masurenguy
12/1/2022
08:56
A few more tucked away @4.31p.

DC

daicaprice
Chat Pages: Latest  69  68  67  66  65  64  63  62  61  60  59  58  Older

Your Recent History

Delayed Upgrade Clock